Patents Assigned to ABBOTT TOXICOLOGY LIMITED
  • Patent number: 11988586
    Abstract: A method of monitoring an immunoassay comprises determining the shape of the flow edge of fluid across an immunoassay region. This allows, for example, early detection of possible errors in the test. The above methods may also be used to provide methods to improve the run conditions of a test during its development. The method may be applied to a competitive assay.
    Type: Grant
    Filed: February 15, 2021
    Date of Patent: May 21, 2024
    Assignee: ABBOTT TOXICOLOGY LIMITED
    Inventors: Timothy John Abbott, David Patrick Edward Brookes
  • Patent number: 11878297
    Abstract: Provided herein is technology relating to testing fluid specimens and particularly, but not exclusively, to apparatuses, devices, methods, systems, and kits for testing a fluid specimen, e.g. urine, saliva, or other body fluids, to detect specified chemical components in the specimen.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: January 23, 2024
    Assignee: ABBOTT TOXICOLOGY LIMITED
    Inventors: Nigel John Fairbank, Jr., Barry Lillis, Timothy John Abbott, Paul Ngui
  • Patent number: 10928288
    Abstract: A method of monitoring an immunoassay comprises determining the shape of the flow edge of fluid across an immunoassay region. This allows, for example, early detection of possible errors in the test. The above methods may also be used to provide methods to improve the run conditions of a test during its development. The method may be applied to a competitive assay.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: February 23, 2021
    Assignee: ABBOTT TOXICOLOGY LIMITED
    Inventors: Timothy John Abbott, David Patrick Edward Brookes